The World Health Organization said Monday it had temporarily suspended clinical trials of hydroxychloriquine as a potential treatment for COVID-19 being carried out across a range of countries as a precautionary measure.The decision came after publication last week of a study in The Lancet which indicated that using the drug on COVID-19 patients could increase…
Last Updated May 15, 2020 7:06 PM EDT The director of the National Institutes of Health (NIH) has said that no corners will be cut in the search for a coronavirus vaccine. But now, there's encouraging news about a potential vaccine that's now being tested on humans and monkeys. NIH researchers in Montana tested the vaccine…
Northwell Health CEO Michael Dowling said that scientists working on a drug trial for famotidine, a common heartburn medication, have "a reasonable confidence" that the drug may make a difference in the treatment of Covid-19 patients. "It's one of many trials we're doing, but we believe in the next two weeks or so we'll have some…
Published: April 27, 2020 at 2:35 a.m. ET A trial in a New York hospital is testing the heartburn medication Pepcid as a treatment for COVID-19, according to a report in Science. Pepcid, a generic drug marketed by Merck MRK, +0.68% and Johnson & Johnson JNJ, -0.41%, is being tested on 187 COVID-19 patients in…
Get all the latest news on coronavirus and more delivered daily to your inbox. Sign up here.A new international trial will examine whether a common anti-inflammatory drug known as colchicine could ward off COVID-19 symptoms and potentially prevent the need for hospitalization for some patients.The study, which has the University of California-San Francisco and New York…
You don't have permission to access "http://www.medpagetoday.com/neurology/generalneurology/120580" on this server. Reference #18.440c3417.1774987346.c6832dac https://errors.edgesuite.net/18.440c3417.1774987346.c6832dac
Your bones could be silently thinning for years before you ever fall and break one in midlife or older age—a fate that strikes up to half of women over 50, double the number of men. At the moment of a fracture, you might not even know you’d developed low bone density, as testing doesn’t usually
States are paying contractors such as Deloitte, Accenture, and Optum millions of dollars to help them comply with the One Big Beautiful Bill Act — a law that will strip safety-net health and food benefits from millions. State governments rely on such companies to design and operate computer systems that assess whether low-income people qualify